FRINGE is a research and innovation action funded under H2020-FETOPEN program that is focused on the development of a genuinely new hybrid-technology for cancer therapy. FRINGE aim is to combine the advantages of both photo-medical and neutron-based therapies to achieve high tumor treatment efficiency as well as large penetration depth in tissue. The NCSRD FRINGE scientific team comprises research scientists from INRASTES, INN and INPT performing proof of principle experiments using accelerator and reactor based neutron sources in Greece and abroad, as well as neutronics calculations to optimize the experimental set-ups and theoretically interpret the results.

Collaborators: OUS, NCSRD, UdG, SYNTHETICA AS, UCT Prague, UPV, IFE and ACCELOPMENT AG

Grant Agreement: This work is carried out in the framework EU H2020 FETOPEN 2018-2019-2020-01 under EU Grand Agreement of 828922